Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis : an individual patient data meta-analysis

Autor: Ahmad, N., Ahuja, S. D., Akkerman, O. W., Alffenaar, J. W. C., Anderson, L. F., Baghaei, P., Bang, D., Barry, P. M., Bastos, M. L., Behera, D., Benedetti, A., Bisson, G. P., Boeree, M. J., Bonnet, Maryline, Brode, S. K., Brust, J. C. M., Cai, Y., Caumes, E., Cegielski, J. P., Centis, R., Chan, P. C., Chan, E. D., Chang, K. C., Charles, M., Cirule, A., Dalcolmo, M. P., D'Ambrosio, L., de Vries, G., Dheda, K., Esmail, A., Flood, J., Fox, G. J., Frechet-Jachym, M., Fregona, G., Gayoso, R., Gegia, M., Gler, M. T., Gu, S., Guglielmetti, L., Holtz, T. H., Hughes, J., Isaakidis, P., Jarlsberg, L., Kempker, R. R., Keshavjee, S., Khan, F. A., Kipiani, M., Koenig, S. P., Koh, W. J., Kritski, A., Kuksa, L., Kvasnovsky, C. L., Kwak, N., Lan, Z. Y., Lange, C., Laniado-Laborin, R., Lee, M., Leimane, V., Leung, C. C., Leung, E. C. C., Li, P. Z., Lowenthal, P., Maciel, E. L., Marks, S. M., Mase, S., Mbuagbaw, L., Migliori, G. B., Milanov, V., Miller, A. C., Mitnick, C. D., Modongo, C., Mohr, E., Monedero, I., Nahid, P., Ndjeka, N., O'Donnell, M. R., Padayatchi, N., Palmero, D., Pape, J. W., Podewils, L. J., Reynolds, I., Riekstina, V., Robert, J., Rodriguez, M., Seaworth, B., Seung, K. J., Schnippel, K., Shim, T. S., Singla, R., Smith, S. E., Sotgiu, G., Sukhbaatar, G., Tabarsi, P., Tiberi, S., Trajman, A., Trieu, L., Udwadia, Z. F., van der Werf, T. S., Veziris, N., Viiklepp, P., Vilbrun, S. C., Walsh, K., Westenhouse, J., Yew, W. W., Yim, J. J., Zetola, N. M., Zignol, M., Menzies, D., Collaborative Group Meta-Analysis

Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______932::3ef87a587a5f3deafcd5e782b67f464b
http://www.documentation.ird.fr/hor/fdi:010074011

Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs

Autor: Bastos, Mayara L., Hussain, Hamidah, Weyer, Karin, Garcia-Garcia, Lourdes, Leimane, Vaira, Leung, Chi Chiu, Narita, Masahiro, Penã, Jose M., Ponce-de-Leon, Alfredo, Seung, Kwonjune J., Shean, Karen, Sifuentes-Osornio, José, Van der Walt, Martie, Van der Werf, Tjip S., Yew, Wing Wai, Menzies, Dick, Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Becerra, M., Benedetti, A., Burgos, M., Centis, R., Chan, E.D., Chiang, C.Y., Cobelens, F., Cox, H., D'Ambrosio, L., de Lange, W.C.M., DeRiemer, K., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Granich, R.M., Hollm-Delgado, M.G., Holtz, T.H., Hopewell, P., Iseman, M., Jarlsberg, L.G., Keshavjee, S., Kim, H.R., Koh, W.J., Lancaster, J., Lange, C., Leimane, V., Leung, C.C., Li, J., Menzies, D., Migliori, G.B., Mitnick, C.M., Narita, M., Nathanson, E., Odendaal, R., O'Riordan, P., Pai, M., Palmero, D., Park, S.K., Pasvol, G., Pena, J., Pérez-Guzmán, C., Ponce-de-Leon, A., Quelapio, M.I.D., Quy, H.T., Riekstina, V., Robert, J., Royce, S., Salim, M., Schaaf, H.S., Seung, K.J., Shah, L., Shean, K., Shim, T.S., Shin, S.S., Shiraishi, Y., Sifuentes-Osornio, J., Sotgiu, G., Strand, M.J., Sung, S.W., Tabarsi, P., Tupasi, T.E., Vargas, M.H., van Altena, R., van der Walt, M., van der Werf, T.S., Viiklepp, P., Westenhouse, J., Yew, W.W., Yim, J.J.

Publikováno v: Clinical Infectious Diseases, 59(10), 1364-1374. Oxford University Press

Background. Individualized treatment for multidrug-resistant (MDR) tuberculosis and extensively drug-resistant (XDR) tuberculosis depends upon reliable and valid drug susceptibility testing (DST) for pyrazinamide, ethambutol, and second-line tubercul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aca2924b5fea5aa25b8b9969b0d7f7e8
https://hdl.handle.net/11370/f2d266b1-ab02-4947-a364-1639c8341937

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis

Autor: Kf, Laserson, Le, Thorpe, Leimane V, Weyer K, Cd, Mitnick, Riekstina V, Zarovska E, Ml, Rich, Hamish Fraser, Alarcón E, Jp, Cegielski, Grzemska M, Gupta R, Espinal M

Publikováno v: Europe PubMed Central

Globally it is estimated that 273000 new cases of multidrug-resistant tuberculosis (MDR-TB, resistance to isoniazid and rifampicin) occurred in 2000. To address MDR-TB management in the context of the DOTS strategy, the World Health Organization and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6e0b5c68160707e8f3fb911e37cba3c6
https://pubmed.ncbi.nlm.nih.gov/15971391

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.